Rankings
▼
Calendar
LQDA Q4 2022 Earnings — Liquidia Corporation Revenue & Financial Results | Market Cap Arena
LQDA
Liquidia Corporation
$3B
Q4 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$5M
+66.7% YoY
Gross Profit
$5M
87.1% margin
Operating Income
-$6M
-121.2% margin
Net Income
-$7M
-121.9% margin
EPS (Diluted)
$-0.10
QoQ Revenue Growth
+69.4%
Cash Flow
Operating Cash Flow
-$5M
Free Cash Flow
-$5M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$129M
Total Liabilities
$39M
Stockholders' Equity
$90M
Cash & Equivalents
$93M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$5M
$3M
+66.7%
Gross Profit
$5M
$2M
+87.5%
Operating Income
-$6M
-$11M
+42.8%
Net Income
-$7M
-$12M
+43.5%
← FY 2022
All Quarters
Q1 2023 →